Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

1.0K
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
1.0K
Relative Risk01:12

Relative Risk

2.2K
Relative risk (RR) is a statistical measure commonly used in epidemiology to compare the likelihood of a particular event occurring between two groups. This metric is important for evaluating the relationship between exposure to a specific risk factor and the probability of a particular outcome. It plays a crucial role in medical research, public health studies, and risk assessment. Relative risk quantifies how much more (or less) likely an event is to occur in an exposed group compared to an...
2.2K
Overview of the Cardiovascular System01:14

Overview of the Cardiovascular System

12.2K
The cardiovascular system is a vital transportation system in the body. It comprises the heart and blood vessels and facilitates the exchange of gases, nutrients, and waste products.
Heart
The heart is the central pump of the cardiovascular system that circulates blood throughout the body. It comprises two atria receiving the blood and two ventricles pumping blood out of the heart. Their rhythmic contractions, called heartbeats, ensure that blood flow remains continuous.
Blood Vessels
Blood...
12.2K
Regulation of the Cardiovascular System01:27

Regulation of the Cardiovascular System

4.1K
The regulation of the cardiovascular system allows the body to adapt to various demands and maintain homeostasis.
The regulation of the cardiovascular system involves the autonomic nervous system (ANS), baroreceptors, and chemoreceptors, ensuring that heart rate and blood pressure are appropriately modulated in response to varying physiological demands.
The ANS comprises two main divisions: the sympathetic and parasympathetic nervous systems. The sympathetic nervous system enhances...
4.1K
Factors Affecting the Risk of Infection01:26

Factors Affecting the Risk of Infection

13.8K
The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
13.8K
Exercise and Cardiovascular Response01:20

Exercise and Cardiovascular Response

4.6K
Exercise significantly impacts cardiovascular response, which is crucial for understanding patient health and designing effective treatment plans.
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
4.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

DPP-4 inhibitors in current diabetes care: their foundational role in treating to target.

Diabetes research and clinical practice·2026
Same author

The role of bempedoic acid in the management of dyslipidaemia in people with diabetes: an expert opinion of Italian diabetologists.

Cardiovascular diabetology·2026
Same author

Implementing sodium-glucose co-transporter 2 inhibitors in cardiovascular-kidney-metabolic syndrome: a multidisciplinary expert perspective.

European heart journal. Cardiovascular pharmacotherapy·2026
Same author

Revisiting the burden and patterns of myocardial infarction in type 1 diabetes.

The lancet. Diabetes & endocrinology·2026
Same author

Discontinuation of incretin-based therapies in obesity: the complexity of a breakup.

European journal of internal medicine·2026
Same author

The combination of glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter-2 inhibitors: a narrative review of existing meta-analysis.

Acta diabetologica·2026
Same journal

Giornale italiano di cardiologia (2006)·2026
Same journal

[Green paper ANMCO: Environmental sustainability in cardiology: a shared commitment of healthcare professionals].

Giornale italiano di cardiologia (2006)·2026
Same journal

[Bempedoic acid in real-world clinical practice: baseline and 8-week data from the Italian prospective, non-interventional MILOS study].

Giornale italiano di cardiologia (2006)·2026
Same journal

[Ranolazine: established indications and emerging therapeutic potential].

Giornale italiano di cardiologia (2006)·2026
Same journal

[Kawasaki disease: the update of American Heart Association guidelines. What adult cardiologists need to know].

Giornale italiano di cardiologia (2006)·2026
Same journal

[The application of artificial intelligence in arrhythmology].

Giornale italiano di cardiologia (2006)·2026
See all related articles

Related Experiment Video

Updated: Feb 12, 2026

Author Spotlight: Assessing the Cardiovascular Profile of Patients with Metabolic Syndrome
06:04

Author Spotlight: Assessing the Cardiovascular Profile of Patients with Metabolic Syndrome

Published on: September 27, 2024

1.5K

[Hypoglycemia and cardiovascular risk].

Angelo Avogaro

    Giornale Italiano Di Cardiologia (2006)
    |January 28, 2015
    PubMed
    Summary
    This summary is machine-generated.

    Intensive diabetes treatment aiming for low glycated hemoglobin (HbA1c) did not reduce cardiovascular deaths. Severe hypoglycemia from these therapies may negate cardiovascular benefits in diabetic patients.

    More Related Videos

    Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
    07:51

    Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis

    Published on: September 26, 2018

    8.1K
    Fundus Photography as a Convenient Tool to Study Microvascular Responses to Cardiovascular Disease Risk Factors in Epidemiological Studies
    10:11

    Fundus Photography as a Convenient Tool to Study Microvascular Responses to Cardiovascular Disease Risk Factors in Epidemiological Studies

    Published on: October 22, 2014

    19.7K

    Related Experiment Videos

    Last Updated: Feb 12, 2026

    Author Spotlight: Assessing the Cardiovascular Profile of Patients with Metabolic Syndrome
    06:04

    Author Spotlight: Assessing the Cardiovascular Profile of Patients with Metabolic Syndrome

    Published on: September 27, 2024

    1.5K
    Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
    07:51

    Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis

    Published on: September 26, 2018

    8.1K
    Fundus Photography as a Convenient Tool to Study Microvascular Responses to Cardiovascular Disease Risk Factors in Epidemiological Studies
    10:11

    Fundus Photography as a Convenient Tool to Study Microvascular Responses to Cardiovascular Disease Risk Factors in Epidemiological Studies

    Published on: October 22, 2014

    19.7K

    Area of Science:

    • Endocrinology and Metabolism
    • Cardiovascular Disease in Diabetes

    Background:

    • Intensive glycemic control with glycated hemoglobin (HbA1c) targets below 7.0% has not demonstrated improved cardiovascular mortality in diabetic patients.
    • Severe and recurrent hypoglycemia episodes are increasingly recognized as a potential contributor to the lack of cardiovascular benefit observed in intensive glucose-lowering therapy trials.

    Purpose of the Study:

    • To discuss the cardiovascular effects of hypoglycemia in the context of diabetes management.
    • To review clinical trials investigating intensive glucose-lowering strategies and their impact on microvascular and macrovascular complications.
    • To clarify the cardiovascular implications of current non-insulin antidiabetic drugs that do not induce hypoglycemia.

    Main Methods:

    • Review of existing literature on intensive glycemic control in diabetes.
    • Analysis of cardiovascular outcomes from major clinical trials focusing on glucose-lowering strategies.
    • Evaluation of the safety and cardiovascular profiles of non-hypoglycemia-inducing diabetes medications.

    Main Results:

    • Intensive glycemic control strategies have not shown a reduction in cardiovascular mortality.
    • Hypoglycemia, particularly severe episodes, is a significant concern associated with intensive glucose-lowering therapies.
    • Certain non-insulin medications for diabetes exhibit neutral or potentially beneficial cardiovascular effects without increasing hypoglycemia risk.

    Conclusions:

    • The failure to observe cardiovascular benefits with intensive glycemic control may be linked to the adverse effects of hypoglycemia.
    • Future diabetes treatment strategies should consider the cardiovascular risks associated with hypoglycemia and prioritize safer glucose-lowering agents.
    • Non-insulin drugs that avoid hypoglycemia represent a promising therapeutic option for managing diabetes and its cardiovascular complications.